Previous 10 | Next 10 |
3 Ways That Market Trends Impact Penny Stocks Performance Market trends can have a significant impact on the performance of penny stocks. Understanding these trends can help investors identify opportunities and make informed investment decisions. One way that market trends can impact pe...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Connect world / Shutterstock.com GeneDx (NASDAQ: WGS ) stock is taking a beating on Friday after the company revealed a proposed public stock offering . According to a press release, GeneDx intends to rai...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: arfa adam / Shutterstock.com ContraFect (NASDAQ: CFRX ) stock is falling on Friday after the company provided an update on its potential delisting from the Nasdaq Capital Market . ContraFect notes in a ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Akanda (NASDAQ: AKAN ) stock is on the rise Friday as the company’s shares continue a rally that started yesterday. That rally was kicked off by an update from the U.S. Food and Drug ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com Redhill Biopharma (NASDAQ: RDHL ) stock is rocketing higher on Friday after getting positive patent news from the U.S. Patent and Trademark Office (USPTO). The USPTO issue...
RedHill Biopharma ( NASDAQ: RDHL ) said that the U.S. Patent and Trademark Office (USPTO) issued a notice of allowance for a patent covering RHB-204's oral fixed-dose combination, methods treating pulmonary Mycobacterium avium Complex (MAC) disease. The patent will also cove...
RedHill Receives USPTO Notice of Allowance for a Patent Covering Phase 3-stage RHB-204 for the Treatment of NTM Disease PR Newswire Once issued, the patent is expected to extend protection of RHB-204 to 2041 RHB-204 is currently undergoing a Phase 3 study in the U.S. a...
Israel-based RedHill Biopharma ( NASDAQ: RDHL ) on Tuesday said results from its phase two study of its antiviral RHB-107 for the treatment of COVID-19 was published in the peer-reviewed International Journal of Infectious Diseases. U.S.-listed shares of the micro-cap specialty biopha...
RedHill Announces Publication of Positive Phase 2 Study Results with Once-Daily Oral RHB-107 in Non-Hospitalized COVID-19 PR Newswire Positive data from a U.S. Phase 2 study of once-daily oral RHB-107 (upamostat) in symptomatic COVID-19 published in the peer-reviewed Internati...
NEW YORK, NY / ACCESSWIRE / December 7, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on an $8 Million Underwritten Public Offering for RedHill Biopharma Ltd. (NASDAQ:RDHL). About RedHill Biopharma Ltd. RedHill Biopharma Ltd. is a specialty biopharmaceutical company primarily focused o...
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
Redhill Biopharma Ltd. Website:
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...
RedHill Announces a New Patent Covering Opaganib in Combination with Immune Checkpoint Inhibitors, Valid Through 2040 PR Newswire New Chinese patent notice of allowance issued covering opaganib in combination with immune checkpoint inhibitors (ICIs) as a method of inducing an ...